Spark Biomedical Sets Sights on Global Expansion with New ISO 13485 and MDSAP Certifications
18. November 2024 10:48 ET
|
Spark Biomedical
Dallas, TX, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Spark Biomedical, a leading developer of wearable neurostimulation devices, proudly announces the recent achievement of ISO 13485:2016 and MDSAP Quality...
Pain Management Devices Market Report 2024 and Company Benchmarking for Abbott, Medtronic, Zynex Medical, Boston Scientific and OMRON Healthcare
22. Oktober 2024 07:15 ET
|
Research and Markets
Dublin, Oct. 22, 2024 (GLOBE NEWSWIRE) -- The "Pain Management Devices Market, Industry Trends and Global Forecasts to 2035: Distribution by Type of Device, Type of Neurostimulation Device,...
Spark Biomedical Awarded National Institute on Drug Abuse Funding to Develop AI-Algorithm for Opioid Withdrawal and Cravings Detection
12. September 2024 13:39 ET
|
Spark Biomedical
Dallas, TX, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Spark Biomedical, a leader in wearable neurostimulation technology, is partnering with prestigious research and behavioral health institutes, Battelle...
Spark Biomedical Introduces Sparrow Link: A Revolutionary Research Platform for Non-Invasive Neurostimulation
05. September 2024 09:00 ET
|
Spark Biomedical
Dallas, TX, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Spark Biomedical, a global pioneer in wearable neurostimulation solutions, proudly announces the launch of Sparrow Link, a revolutionary research...
Lungpacer Medical Announces PMA Submission for AeroPace® System
04. September 2024 09:00 ET
|
Lungpacer Medical USA Inc.
Lungpacer Medical today announced that its AeroPace System is under Food and Drug Administration (FDA) review in a premarket approval (PMA) application.
Behind the Scenes of Medical Innovation: Spark Biomedical launches new web series ‘Spark a Conversation’
01. Juli 2024 09:48 ET
|
Spark Biomedical
Dallas, TX, July 01, 2024 (GLOBE NEWSWIRE) -- For as long as there has been opioid use disorder, there have only been two solutions: cold turkey or more drugs. The founders of Spark Biomedical...
Neurotechnology Research Report 2024: Market Set to Surge, North America Leads Growth Trajectory - Long-term Forecast to 2028 and 2033
30. Januar 2024 10:49 ET
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Neurotechnology Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The report reveals that the neurotechnology...
Global Neurostimulation Technology and Market Research Report 2023 Featuring Major Players - Axonics, Boston Scientific, Medtronic, Synapse Biomedical, and Xavant Technology
13. Dezember 2023 07:23 ET
|
Research and Markets
Dublin, Dec. 13, 2023 (GLOBE NEWSWIRE) -- The "Neurostimulation: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering. This report provides a comprehensive...
Neurostimulation Market Surges with a Promising CAGR of 9.5% through 2033, Projected to Reach a Valuation of US$ 15,417.4 Million | Future Market Insights Inc.
14. November 2023 12:00 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, DEL, Nov. 14, 2023 (GLOBE NEWSWIRE) -- The global neurostimulation market value is expected to rise from US$ 6,221.2 million in 2023 to US$ 15,417.4 million by 2033. This estimated growth is...
Global Neurostimulation Devices Market Expected to Reach $11.34 Billion by 2028: Players Include Medtronic, Cyberonics, Boston Scientific and Abbott Laboratories
16. Oktober 2023 05:38 ET
|
Research and Markets
Dublin, Oct. 16, 2023 (GLOBE NEWSWIRE) -- The "Neurostimulation Devices - Global Market Insights, Competitive Landscape, and Market Forecast - 2028" report has been added to ...